Δ value of HLA markers in SLE patients and the clinical and serological manifestations
| SLE | TAP2*01 δ=0.87 | DQA1*0501 δ=0.45 | DR3 δ=0.34 | DR13 δ=0.21 | ||||
|---|---|---|---|---|---|---|---|---|
| DPGN+ | DR3 | DQA1*0501 | DQB1*0201 | DQB1*0604 | ||||
| δ=0.72 | δ=0.57 | δ=0.56 | δ=0.13 | |||||
| DPGN− | DQA1*0501 | DR13 | DQB1*0301 | DR11 | DR3 | |||
| δ=0.47 | δ=0.32 | δ=0.30 | δ=0.22 | δ=0.22 | ||||
| Ro | DR3+ | DQA1*0501+ | DQB1*0201+ | DQB1*0201 | TAP2*01/01 | DQA1*0501 | DR3 | |
| TAP2*01/01 | TAP2*01/01 | TAP2*01/01 | ||||||
| δ=0.86 | δ=0.83 | δ=0.80 | δ=0.68 | δ=0.67 | δ=0.53 | δ=0.52 | ||
| Ro/La | DQA1*0501 | DQB1*0201 | DR3 | DR13 | ||||
| δ=1 | δ=1 | δ=0.82 | δ=0.40 | |||||
| Ro alone | TAP2*01/01+ | TAP2*01/01 | DR11 | |||||
| DR11 | ||||||||
| δ=1 | δ=0.81 | δ=0.30 | ||||||